SCHEMBL19900284

SCHEMBL19900284

Cc1nc(N2CCC2)nc(N2CCC2)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ GBA1 P04062 1/20 0.41
▸ POLB P06746 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HTT P42858 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19900143 0.77 ALDH1A1 (0.51) ALDH1A1GBA1CYP1A2MEN1KMT2A
SCHEMBL19900144 0.71 ALDH1A1 (0.36) ALDH1A1POLBSMN1; SMN2MEN1KMT2A
SCHEMBL19900199 0.71 CHRM3 (0.36) ALDH1A1CYP1A2CHRM3PDE4APDE4B
SCHEMBL15055333 0.71 CHRM3 (0.46) ALDH1A1SMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL15246924 0.70 ALDH1A1 (0.52) ALDH1A1GBA1POLBSMN1; SMN2CYP1A2
SCHEMBL19899801 0.70 NPY5R (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL19900131 0.70 NPY5R (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL18005531 0.70 KDM4E (0.35) ALDH1A1POLBSMN1; SMN2MEN1KMT2A
SCHEMBL18280292 0.69 CHRM3 (0.49) ALDH1A1SMN1; SMN2CYP1A2CHRM3PDE4A
SCHEMBL9803306 0.68 HRH1 (0.62) ALDH1A1SMN1; SMN2CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595250-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2026-04-07 — — US disclosed
US-20220324841-A1 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-10-13 — — US disclosed
US-11390605-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2022-07-19 — — US disclosed
US-20210276979-A1 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-09-09 — — US disclosed
US-20210276979-A1 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-09-09 — — US disclosed
WO-2018039077-A1 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-03-01 — — WO disclosed
WO-2018039077-A1 THERAPEUTIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-03-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595250-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses GSR, UQCRC1, TXNRD2 ALDH1A1 573/4885GBA1 777/4885POLB 695/4885
US-20220324841-A1 THERAPEUTIC COMPOUNDS CFTR, F12, FURIN ALDH1A1 674/4885GBA1 31/4885POLB 4601/4885
US-20210276979-A1 THERAPEUTIC COMPOUNDS CFTR, F12, FURIN ALDH1A1 674/4885GBA1 31/4885POLB 4601/4885
US-11390605-B2 Substituted pyrimidine compounds as multifunctional radical quenchers and their uses DPYD, TYMP, NUDT1 ALDH1A1 599/4885GBA1 2092/4885POLB 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback